Your browser doesn't support javascript.
loading
Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicity.
Punt, Simone; Malu, Shruti; McKenzie, Jodi A; Manrique, Soraya Zorro; Doorduijn, Elien M; Mbofung, Rina M; Williams, Leila; Silverman, Deborah A; Ashkin, Emily L; Dominguez, Ana Lucía; Wang, Zhe; Chen, Jie Qing; Maiti, Sourindra N; Tieu, Trang N; Liu, Chengwen; Xu, Chunyu; Forget, Marie-Andrée; Haymaker, Cara; Khalili, Jahan S; Satani, Nikunj; Muller, Florian; Cooper, Laurence J N; Overwijk, Willem W; Amaria, Rodabe N; Bernatchez, Chantale; Heffernan, Timothy P; Peng, Weiyi; Roszik, Jason; Hwu, Patrick.
Afiliación
  • Punt S; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
  • Malu S; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
  • McKenzie JA; Immunitas Therapeutics, Cambridge, MA, USA.
  • Manrique SZ; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
  • Doorduijn EM; Eisai Inc., Woodcliff Lake, NJ, USA.
  • Mbofung RM; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
  • Williams L; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
  • Silverman DA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
  • Ashkin EL; Merck Research Laboratories, Palo Alto, CA, USA.
  • Dominguez AL; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
  • Wang Z; KSQ Therapeutics Inc., Cambridge, MA, USA.
  • Chen JQ; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
  • Maiti SN; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
  • Tieu TN; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
  • Liu C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
  • Xu C; Nature Cell Biology, Springer Nature, Shanghai City, China.
  • Forget MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
  • Haymaker C; EMD Serono, Rockland, MA, USA.
  • Khalili JS; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
  • Satani N; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
  • Muller F; C4 Therapeutics, Watertown, MA, USA.
  • Cooper LJN; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
  • Overwijk WW; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
  • Amaria RN; University of Houston, Houston, TX, USA.
  • Bernatchez C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
  • Heffernan TP; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
  • Peng W; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
  • Roszik J; SystImmune Inc., Redmond, WA, USA.
  • Hwu P; Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Cancer Immunol Immunother ; 70(4): 1101-1113, 2021 Apr.
Article en En | MEDLINE | ID: mdl-33123754
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Linfocitos T Citotóxicos / Linfocitos Infiltrantes de Tumor / Resistencia a Antineoplásicos / Aurora Quinasa A / Aurora Quinasa B / Inmunoterapia / Melanoma Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Linfocitos T Citotóxicos / Linfocitos Infiltrantes de Tumor / Resistencia a Antineoplásicos / Aurora Quinasa A / Aurora Quinasa B / Inmunoterapia / Melanoma Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos